hicn medic news part  cut volum number april    health info com network medic newslett  editor david dodel north nd street suit scottsdal arizona usa telephon fax  compil copyright david dodel right reserv licens herebi grant republish electron medium fee charg long text copyright notic licens attach intact republish portion portion  health info com network newslett distribut biweekli articl medic natur welcom articl plea contact editor inform submit interest join autom distribut system plea contact editor  e mail address editor fidonet anonym ftp vm nodak edu fax deliveri contact editor inform     b l e f c n e n   center diseas control prevent mmwr april rate cesarean deliveri malaria among u embassi personnel fda approv hib vaccin child infant  dental news workshop explor oral manifest hiv infect  food drug administr news fda approv depo provera inject contracept new rule speed approv drug life threaten ill  articl research promis prevent slow blind retin diseas affluent diet increas risk heart diseas  gener announc public health profession nation cancer institut public patient avail nation cancer institut  aid news summari aid daili summari april april  aid statist worldwid aid statist      hicnet medic newslett page volum number april     center diseas control prevent mmwr   rate cesarean deliveri unit state  sourc mmwr date apr  cesarean deliveri account nearli million approxim million annual deliveri unit state sinc tabl cesarean rate unit state third highest among report countri exceed brazil puerto rico report present data cesarean deliveri cdc nation hospit discharg survey nhd compar data previou year data discharg short stay nonfeder hospit collect annual sinc nhd conduct cdc nation center health statist medic demograph inform abstract sampl inpati discharg particip hospit cesarean vagin birth prior cesarean vbac present report base weight nation estim nhd sampl approxim woman discharg deliveri estim number live birth type deliveri calcul appli cesarean rate nhd live birth nation vital registr data therefor estim number cesarean report agre previous publish data base sole nhd state differ analysi signific confid level base two tail test critic valu  cesarean per deliveri rate similar rate tabl primari cesarean rate e number first cesarean per deliveri woman previou cesarean also stabl rang cesarean rate south significantli p higher rate west midwest northeast rate higher mother age greater equal year younger woman proprietari hospit nonprofit govern hospit hospit fewer bed larger hospit deliveri blue cross blue shield privat insur expect sourc payment sourc payment tabl pattern character primari cesarean deliveri sinc earli number percentag birth older woman increas howev age distribut mother remain overal cesarean rate would essenti observ base nhd approxim live birth  hicnet medic newslett page volum number april  estim cesarean deliveri estim birth repeat cesarean primari cesarean sinc approxim primari cesarean perform annual woman previou cesarean deliv vagin compar cesarean associ previou cesarean dystocia e failur labor progress breech present fetal distress specifi complic averag hospit stay deliveri day comparison hospit stay primari cesarean deliveri day repeat cesarean day nearli twice durat vbac deliveri day vagin deliveri vbac day averag hospit stay deliveri day primari cesarean day repeat cesarean day vbac non vbac vagin deliveri day respect  report offic vital health statist system nation center health statist cdc  editori note cesarean rate unit state steadili increas howev find report indic rate stabl sinc littl evid matern child health statu improv time cesarean associ increas risk complic childbirth nation health object year reduc overal cesarean rate fewer per deliveri primari cesarean rate fewer per deliveri object postpartum complic includ urinari tract wound infect may account part longer hospit stay cesarean deliveri vagin birth moreov prolong hospit stay cesarean deliveri substanti increas health care cost exampl averag cost cesarean vagin deliveri respect addit cost cesarean deliveri includ physician fee hospit charg cesarean rate year object instead number cesarean birth would decreas versu result save billion physician fee hospit charg despit steadi increas vbac rate sinc sever factor may imped progress toward year nation health object cesarean deliveri exampl vbac rate substanti reflect number woman offer trial labor increasingli encourag sinc woman offer trial labor could deliv vagin level alreadi achiev mani hospit trial labor routin offer hospit survey recent year  hicnet medic newslett page volum number april  nation data avail vbac rate accord nhd data year object specifi vbac rate base woman prior cesarean regardless whether trial labor attempt reach overal cesarean rate goal howev increas vbac rate need combin substanti reduct primari rate one hospit succeed reduc rate cesarean deliveri appli object criterion four common indic cesarean deliveri requir second opinion institut peer review process recommend decreas cesarean deliveri rate includ elimin incent physician hospit equal reimburs vagin cesarean deliveri public dissemin physician hospit specif cesarean deliveri rate increas public awar differ practic address malpractic concern may import factor maintain high rate cesarean deliveri  refer  notzon fc intern differ use obstetr intervent jama  grave ej nch summari nation hospit discharg survey hyattsvil maryland u depart health human servic public health servic cdc advanc data  taffel sm placek pj kosari cl u cesarean section rate updat birth  public health servic healthi peopl nation health promot diseas prevent object full report commentari washington dc u depart health human servic public health servic dhh public ph  danforth dn cesarean section jama  hospit insur associ america tabl cost matern care physician fee hospit charg censu region base consum price index sourc book health insur data washington dc hospit insur associ america  committe obstetr acog committe opinion guidelin vagin deliveri previou cesarean birth washington dc american colleg obstetrician gynecologist   hicnet medic newslett page volum number april  rosen mg dickinson jc vagin birth cesarean meta analysi indic success obstet gynecol  shiono ph fielden jg mcnelli rhoad gg pear wh recent trend cesarean birth trial labor rate unit state jama   myer sa gleicher n success program lower cesarean section rate n engl j med  use trade name commerci sourc identif impli endors public health servic u depart health human servic                                 hicnet medic newslett page volum number april  malaria among u embassi personnel kampala uganda  sourc mmwr date apr  treatment prevent malaria africa becom challeng complex problem increas drug resist although risk acquir malaria u citizen depend station oversea gener low risk vari substanti unpredict may offic medic servic depart state om cdc notifi increas number malaria case among offici u personnel station kampala uganda review health record embassi health unit ehu kampala indic case malaria diagnos offici personnel march june compar two case period ehu om cdc conduct investig confirm report malaria case identifi potenti risk factor malaria among u embassi personnel report summar result investig malaria blood smear report case patient avail review om cdc case malaria confirm slide posit plasmodium sp person slide confirm malaria questionnair distribut person serv ehu obtain inform resid activ use malaria chemoprophylaxi use person protect measur e use bednet insect repel window door screen wear long sleev pant even person elig survey respond risk malaria associ sex locat resid kampala although risk malaria higher among child age le equal year among person greater year differ signific rel risk rr confid interv ci eighti two percent case occur among person live kampala year compar live le year travel outsid kampala area rural set associ increas risk malaria four malaria chemoprophylaxi regimen use person particip survey mefloquin chloroquin proguanil chloroquin alon proguanil alon addit person respond use malaria chemoprophylaxi risk malaria significantli lower among person use either mefloquin chloroquin proguanil among person use regimen prophylaxi rr ci twelv person use prophylaxi report side effect fear possibl side effect reason risk malaria lower among person report use bednet  hicnet medic newslett page volum number april  time among person sometim rare use bednet rr ci risk malaria also lower among person consist use insect repel even compar rare use repel rr upper confid limit risk malaria associ failur window door screen wear long sleev pant even result investig ehu staff review personnel need use compli recommend malaria chemoprophylaxi regimen ehu staff also emphas need use person protect measur made plan obtain insecticid impregn bednet provid window door screen personnel  report u embassi health unit kampala uganda offic medic svc dept state washington c malaria br div parasit diseas nation center infecti diseas cdc  editori note uganda increas malaria among u personnel attribut poor adher recommend malaria chemoprophylaxi regimen use person protect measur period increas malaria transmiss intensifi chloroquin resist sub saharan africa find report underscor need provid initi continu counsel regard malaria prevent person live abroad malaria endem area prevent measur also import short term travel area mefloquin effect prophylaxi regimen africa area chloroquin resist p falciparum howev area e g thailand resist mefloquin may limit effect africa efficaci mefloquin compar chloroquin alon prevent infect p falciparum mefloquin safe well toler given mg per week year period risk seriou advers reaction possibl associ mefloquin prophylaxi e g psychosi convuls low e episod per user risk le sever advers reaction e g dizzi gastrointestin complaint sleep disturb similar antimalari chemoprophylact doxycyclin similar prophylact efficaci mefloquin need daili dose may reduc complianc effect regimen chloroquin alon effect prophylaxi area intens chloroquin resist e g southeast asia africa africa person take mefloquin doxycyclin chloroquin proguanil altern although le effect regimen chloroquin use malaria prevent area chloroquin resist p falciparum report countri specif recommend prevent malaria inform  hicnet medic newslett page volum number april  dosag precaut malaria chemoprophylaxi regimen avail health inform intern travel e yellow book hour day telephon fax  refer  lobel ho miani eng et al long term malaria prophylaxi weekli mefloquin peac corp volunt effect well toler regimen lancet  world health organ review central nervou system advers event relat antimalari drug mefloquin geneva world health organ public mal  pang l limsomwong n singharaj p prophylact treatment vivax falciparum malaria low dose doxycyclin j infect di  pang l limsomwong n boudreau ef singharaj p doxycyclin prophylaxi falciparum malaria lancet  cdc health inform intern travel atlanta u depart health human servic public health servic dhh public cdc                       hicnet medic newslett page volum number april  fda approv use new haemophilu b conjug vaccin combin diphtheria tetanu pertussi haemophilu b conjug vaccin infant child  sourc mmwr date apr  haemophilu influenza type b hib conjug vaccin recommend use infant sinc routin use infant vaccin contribut substanti declin incid hib diseas unit state vaccin diphtheria tetanu pertussi infanc childhood administ routin unit state sinc late associ greater reduct morbid mortal associ infect organ increas number vaccin routin recommend infant high prioriti develop combin vaccin allow simultan administr fewer separ inject food drug administr fda recent licens two new product vaccin child diseas haemophilu b conjug vaccin tetanu toxoid conjug acthib trademark vaccin hib diseas combin diphtheria tetanu toxoid whole cell pertussi vaccin dtp hib conjug vaccin tetramun trademark combin vaccin formul use vaccin child diphtheria tetanu pertussi hib diseas  acthib trademark  march fda approv new haemophilu b conjug vaccin polyribosylribitol phosphat tetanu toxoid conjug prp manufactur pasteur merieux serum et vaccin distribut acthib trademark connaught laboratori inc swiftwat pennsylvania vaccin licens use infant three dose primari vaccin seri administ age month previous unvaccin infant month age receiv two dose month apart previous unvaccin child month age receiv one dose booster dose administ month age recommend child previous unvaccin child month age receiv singl dose requir booster infant receiv primari vaccin seri acthib trademark consecut dose month age develop geometr mean titer anti haemophilu b polysaccharid antibodi greater ug ml respons similar infant receiv recommend seri previous licens haemophilu b conjug vaccin efficaci demonstr prospect trial two u efficaci trial prp termin earli concomit licensur haemophilu b conjug vaccin  hicnet medic newslett page volum number april  use infant studi case invas hib diseas detect approxim infant vaccin prp studi suggest efficaci prp vaccin similar licens hib vaccin tetramun trademark march fda approv combin diphtheria tetanu toxoid whole cell pertussi vaccin dtp haemophilu b conjug vaccin tetramun trademark avail lederl praxi biolog pearl river new york combin two previous licens product dtp triimmunol regist manufactur lederl laboratori pearl river new york haemophilu b conjug vaccin hibtit regist manufactur praxi biolog inc rochest new york vaccin licens use child age month year protect diphtheria tetanu pertussi hib diseas indic vaccin dtp vaccin haemophilu b conjug vaccin coincid base demonstr co mparabl higher antibodi respons compon two vaccin tetramun trademark expect provid protect hib well diphtheria tetanu pertussi equival alreadi licens formul dtp haemophilu b vaccin advisori committe immun practic acip recommend infant receiv primari seri one licens haemophilu b conjug vaccin begin month age booster dose age month acip also recommend infant receiv four dose primari seri diphtheria tetanu toxoid pertussi vaccin month age booster dose year complet statement regard recommend use acthib trademark tetramun trademark develop  report offic vaccin research review center biolog evalu research food drug administr div immun nation center prevent svc mening special pathogen br div bacteri mycot diseas nation center infecti diseas cdc  refer  adam wg deaver ka cochi sl et al declin childhood haemophilu influenza type b hib diseas hib vaccin era jama  broadhurst le erickson rl kelley pw decreas invas haemophilu influenza diseas u armi child jama   murphi tv white ke pastor p et al declin incid haemophilu influenza type b diseas sinc introduct vaccin jama  hicnet medic newslett page volum number april    fritzel b plotkin efficaci safeti haemophilu influenza type b capsular polysaccharid tetanu protein conjug vaccin j pediatr   acip haemophilu b conjug vaccin prevent haemophilu influenza type b diseas among infant child two month age older recommend immun practic advisori committe acip mmwr rr  acip diphtheria tetanu pertussi recommend vaccin use prevent measur recommend immun practic advisori committe acip mmwr rr  acip pertussi vaccin acellular pertussi vaccin reinforc booster use supplementari acip statement recommend immun practic advisori committe acip mmwr rr  acip pertussi vaccin acellular pertussi vaccin fourth fifth dose dtp seri updat supplementari acip statement recommend immun practic advisori committe acip mmwr rr  use trade name commerci sourc identif impli endors public health servic u depart health human servic                   hicnet medic newslett page volum number april     dental news   intern workshop explor oral manifest hiv infect  nidr research digest written jodi dove march nation institut dental research  second intern workshop oral manifest hiv infect held januari februari san francisco particip explor issu relat epidemiolog basic molecular virolog mucos immunolog oral clinic present hiv infect workshop organ dr john greenspan dr deborah greenspan depart stomatolog school dentistri univers california san francisco intern steer committe scientif program committe provid guidanc confer drew scientist countri includ asia africa europ central america south america well unit state canada support tor workshop provid nation institut dental research nation cancer institut nation institut allergi infecti diseas nih offic aid research procter gambl compani among topic discus epidemiolog hiv lesion ethic profession respons public polici occup issu provis oral care hiv posit popul salivari hiv transmiss mucos immun opportunist infect pediatr hiv infect woman issu  recommend  recommend emerg workshop defin associ appear oral lesion rate progress hiv establish univers terminolog hiv associ oral lesion look effect treatment oral manifest expand molecular biolog studi understand relationship hiv infect common oral lesion studi effect hiv therapi oral lesion  epidemiolog  sinc first intern workshop oral manifest hiv infect conven five year ago epidemiolog hiv infect  hicnet medic newslett page volum number april  radic chang hiv infect detect report larg homosexu bisexu male intraven drug user hemophiliac today hiv infect seen heterosexu male femal child adolesc predomin impact hiv infect felt africa major increas infect rate seen southeast asia well five hundr thousand case report date region appear time research continu document epidemiolog oral lesion hairi leukoplakia candidiasi also begin explor relationship specif oral lesion hiv diseas progress prognosi  social polit issu  discus social polit implic hiv infect focus chang public attitud aid retribut indiscrimin sexual behavior drug use speaker also address health care deliveri hiv infect patient need educ public aid acquir  saliva salivari gland  confer speaker describ transmiss issu hiv inhibitori activ saliva strength vari among differ salivari secret whole saliva greater inhibitori effect submandibular secret turn greater inhibitori effect parotid secret research shown least two mechan respons salivari inhibitori activ attribut hiv inhibitori effect saliva aggreg agglutin hiv saliva may promot clearanc viru prevent reach target cell direct effect viru target cell topic discus manifest salivari gland diseas hiv infect person current research oral mucos immun  pediatr issu  pediatr aid recent emerg area intens interest earli accur diagnosi proper treatment life expect hiv infect child tripl prevent transmiss hiv mother child may possibl mani case particularli mother sero statu known prior give birth  periodont gingiv tissu diseas   hicnet medic newslett page volum number april  oral health research continu explor periodont diseas gingiv found individu hiv infect recommend made workshop includ standard terminolog refin diagnost marker standard studi design proper consider confound variabl result periodont therapi  occup treatment issu  occup issu surround treatment hiv infect individu treatment render hiv infect health care profession still command consider attent factor consider includ cost benefit hiv test patient health care provid transmiss hiv infect revers use mainstream versu dedic facil treatment hiv infect patient confer particip anticip third intern workshop oral manifest hiv infect held five year le proceed second workshop publish quintess compani late                       end part   